The Molecular Determinants of Virus Induced Biliary Atresia
病毒引起的胆道闭锁的分子决定因素
基本信息
- 批准号:8449192
- 负责人:
- 金额:$ 34.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferAmino AcidsAntigen-Presenting CellsAutoimmune ProcessBiliaryBiliary AtresiaBindingBiological AssayCD8B1 geneCOS-7 CellCapsidCell surfaceCellsCharacteristicsChildChildhoodCholestasisComplexDendritic CellsDiseaseDouble Stranded RNA VirusDouble-Stranded RNAEnvironmentEpithelialEpithelial CellsEpitheliumEpitopesEtiologyGene ProteinsGenerationsGenesGeneticGenomeGoalsHepaticImmuneImmune responseImmunoprecipitationIn VitroInbred BALB C MiceInfantInfectionInflammationInjuryKnock-in MouseKnock-outLiverLiver diseasesMHC Class I GenesMacaca mulattaMediatingMessenger RNAMissionModelingMolecularMusMutateMutationNatureNewborn InfantObstructionParentsPathogenesisPeptidesPerinatalPlasmidsPlayProcessProductionPropertyProteinsRecombinantsRestRoleRotavirusRotavirus InfectionsSCID MiceSequence AnalysisSiteStagingT cell responseT-Cell ActivationT-Cell ReceptorT-LymphocyteT7 RNA polymeraseTestingTranslatingTropismUnited States National Institutes of HealthVaccinia virusViralViral PathogenesisVirusVirus Diseasesbasecholangiocytedisabilityfunctional statusgene cloningin vitro Modelin vivoinsightinterestknockout geneliver transplantationpathogenpositional cloningpromoterprotein aminoacid sequencepublic health relevancethree-dimensional modelingtooltreatment strategy
项目摘要
DESCRIPTION (provided by applicant): Biliary atresia is the most common cause of pediatric end stage liver disease and the number one indication for pediatric liver transplantation. Because pathogenic viruses have been found in the liver of afflicted children, a proposed etiology for biliary atresia is a perinatal viral infection triggering immune mediated destruction of the biliary epithelium. The murine model of biliary atresia supports a viral pathogenesis as newborn mice infected with rhesus rotavirus (RRV) develop inflammation within the portal tract and extra- hepatic bile duct obstruction. RRV targets the cholangiocyte for infection and in addition to direct cholangiocyte injury also induces T-cell mediated injury to the biliary epithelium. Rotavirus is a dsRNA virus comprised of 11 gene segments. We hypothesized that specific rotavirus genes govern the ability to infect the cholangiocyte and induce immune mediated injury. To test this hypothesis, we generated a complete set of single gene reassortants derived from the parental strains RRV and TUCH. These reassortants give us a unique set of tools to determine how specific rotavirus genes contribute to the pathogenesis. In preliminary studies, we found that RRV segments 3, 4, 6, 8, 9 and 11 are genes of interest. Given the robust nature of the observations made with gene segment 4, we focused on this gene. We will use in vitro models of RRV - cholangiocyte infection and T-cell activation to determine the mechanisms by which gene segment 4 contributes to disease pathogenesis. We will also use reverse genetics to generate mutate gene segment 4 infectious virus to determine the basis in the more complex environment of the intact host. These complimentary approaches will generate new insight in viral induced biliary atresia.
描述(由申请人提供):胆道闭锁是小儿终末期肝病的最常见原因,也是小儿肝移植的第一指示。由于已在患病儿童的肝脏中发现了致病性病毒,因此提出的用于胆道闭锁的病因是一种围产期病毒感染,引发了免疫介导的胆道上皮的破坏。胆道闭锁的鼠模型支持病毒发病机理,因为感染了轮状病毒恒河猴(RRV)的新生小鼠在门户区域内发生炎症和肝外胆管阻塞。 RRV靶向胆管细胞感染,除了直接的胆管细胞损伤外,还会诱导T细胞介导的胆道上皮损伤。 轮状病毒是由11个基因段组成的DSRNA病毒。我们假设特定的轮状病毒基因控制感染胆管细胞并诱导免疫介导的损伤的能力。为了检验这一假设,我们生成了一组源自父母菌株RRV和TUCH的单个基因reastrants。这些可重构的物体为我们提供了一套独特的工具,可以确定轮状病毒基因如何促进发病机理。在初步研究中,我们发现RRV段3、4、6、8、9和11是感兴趣的基因。鉴于用基因段4进行的观察的强大性质,我们专注于该基因。我们将使用RRV-胆管细胞感染和T细胞激活的体外模型来确定基因段4促进疾病发病机理的机制。我们还将使用反向遗传学来生成突变的基因段4感染性病毒,以确定完整宿主更复杂的环境中的基础。这些免费方法将产生有关病毒诱导胆道闭锁的新见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREGORY M TIAO其他文献
GREGORY M TIAO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREGORY M TIAO', 18)}}的其他基金
The Molecular Determinants of Virus Induced Biliary Atresia
病毒引起的胆道闭锁的分子决定因素
- 批准号:
8085527 - 财政年份:2011
- 资助金额:
$ 34.04万 - 项目类别:
Genetic basis of virus induced Biliary Atresia
病毒引起的胆道闭锁的遗传基础
- 批准号:
10328541 - 财政年份:2011
- 资助金额:
$ 34.04万 - 项目类别:
The Molecular Determinants of Virus Induced Biliary Atresia
病毒引起的胆道闭锁的分子决定因素
- 批准号:
8243504 - 财政年份:2011
- 资助金额:
$ 34.04万 - 项目类别:
Intracellular signaling pathways and virus induced biliary atresia
细胞内信号通路与病毒诱导的胆道闭锁
- 批准号:
7875916 - 财政年份:2010
- 资助金额:
$ 34.04万 - 项目类别:
Intracellular signaling pathways and virus induced biliary atresia
细胞内信号通路与病毒诱导的胆道闭锁
- 批准号:
8051858 - 财政年份:2010
- 资助金额:
$ 34.04万 - 项目类别:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
病毒性胆道闭锁的发病机制
- 批准号:
7261173 - 财政年份:2005
- 资助金额:
$ 34.04万 - 项目类别:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
病毒性胆道闭锁的发病机制
- 批准号:
6961713 - 财政年份:2005
- 资助金额:
$ 34.04万 - 项目类别:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
病毒性胆道闭锁的发病机制
- 批准号:
7121806 - 财政年份:2005
- 资助金额:
$ 34.04万 - 项目类别:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
病毒性胆道闭锁的发病机制
- 批准号:
7637736 - 财政年份:2005
- 资助金额:
$ 34.04万 - 项目类别:
INTRAVENOUS METHYLPREDNISOLONE VS ORAL PREDNISOLONE IN TRANSPLANT REJECTION
静脉注射甲基泼尼松龙与口服泼尼松龙在移植排斥中的比较
- 批准号:
7374506 - 财政年份:2005
- 资助金额:
$ 34.04万 - 项目类别:
相似国自然基金
氨基酸转运体调控非酒精性脂肪肝的模型建立及机制研究
- 批准号:32371222
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
催化不对称自由基反应合成手性α-氨基酸衍生物
- 批准号:22371216
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
特定肠道菌种在氨基酸调控脂质代谢中的作用与机制研究
- 批准号:82300940
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠道菌群紊乱导致支链氨基酸减少调控Th17/Treg平衡相关的肠道免疫炎症在帕金森病中的作用和机制研究
- 批准号:82301621
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
氨基酸调控KDM4A蛋白N-末端乙酰化修饰机制在胃癌化疗敏感性中的作用研究
- 批准号:82373354
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Therapeutic applications of CD4+ T cells specific for oncogenic driver mutations
致癌驱动突变特异性 CD4 T 细胞的治疗应用
- 批准号:
10640078 - 财政年份:2020
- 资助金额:
$ 34.04万 - 项目类别:
Therapeutic applications of CD4+ T cells specific for oncogenic driver mutations
致癌驱动突变特异性 CD4 T 细胞的治疗应用
- 批准号:
9977672 - 财政年份:2020
- 资助金额:
$ 34.04万 - 项目类别:
Therapeutic applications of CD4+ T cells specific for oncogenic driver mutations
致癌驱动突变特异性 CD4 T 细胞的治疗应用
- 批准号:
10378482 - 财政年份:2020
- 资助金额:
$ 34.04万 - 项目类别:
Preserving T cell / antigen presenting cell interactions via shared L-arginine
通过共享 L-精氨酸保留 T 细胞/抗原呈递细胞相互作用
- 批准号:
10240447 - 财政年份:2020
- 资助金额:
$ 34.04万 - 项目类别:
A Novel Combination Therapy for Type 1 Diabetes Prevention
预防 1 型糖尿病的新型联合疗法
- 批准号:
9331929 - 财政年份:2017
- 资助金额:
$ 34.04万 - 项目类别: